Maria Iniesta
@mariainiesta17
ID: 1184648463209897984
17-10-2019 01:53:20
53 Tweet
27 Takipçi
61 Takip Edilen
Definitively! 90% girls vaccinated before 15th 70% women35-45YO screened (HPV detection highly preferred) 90% CC and CIN treated properly That is the way ! Togeter we'll achieved it #WHO STRATEGY FIGO HQ ESGO IGCS IJGC IJGC Fellows Andreas Obermair
I removed the Foley either POD1 or 2 when patient is going home after open #radical #hysterectomy….no need for prolonged catheterization! See this article by @sarah_huep MD Anderson News IJGC IJGC Fellows ESGO European Network of Young Gynae Oncologists SGO SoMe4GynOnc
Pedro T Ramirez Elsevier IJGC IJGC Fellows ESGO European Network of Young Gynae Oncologists IGCS SGO SoMe4GynOnc Working on my chapter revisions 😂 thanks for the opportunity to contribute 👏
So excited to be speaking about #ERAS in #GynOnc to ECHO-ELA 2.0 on Sept 16! Come join us 👏 Project ECHO @NCICRCHD NIH MD Anderson News @Dr_San_Miguel PAHO/WHO ERAS® Society SGO IGCS ESGO Kathleen Schmeler MD SoMe4GynOnc
Congratulations to Kathleen Schmeler MD #IJGC Editor’s choice award recipient for #ConCerv trial. IGCS ESGO Pedro T Ramirez #GynOnc #CervicalCancer #IGCS2022 #surgery Arthur_HC_Hsu Christina Uwins Ane Gerda Z Eriksson MD PhD
Does KetaDex (opioid-sparing anesthesia) improve patient-reported outcomes (PROs)? Check out our latest study in CJA - Canadian Journal of Anesthesia comparing #PROs between opioid-sparing vs opioid-based anesthesia in gynecologic surgery. Link: tinyurl.com/5252cus7
For years, we’ve collaborated with the World Health Organization on our shared health initiatives. Today, we’re proud to build upon this collaboration to help prevent breast and cervical cancers around the world: fal.cn/3sUkc World Health Organization (WHO) Peter WT Pisters, MD Kathleen Schmeler MD #EndCancer
The future of neoadjuvant chemotherapy in #BRCA mutated #ovariancancer Shannon Westin, MD, MPH, FASCO MD Anderson News #SGOMtg #sgo2023 #oncsurgery #gyncsm
⭐️Applying universal germline testing to patients with cancer routinely is one of the major opportunities that can revolutionize #PrecisionMedicine practice OncoAlert Journal of Clinical Oncology ASCO The ASCO Post
Lynch syndrome creates the perfect context for vaccine development targeting the molecular origins that develop tumors. Our Dr. Eduardo Vilar-Sanchez explains here: fal.cn/3y8RI FOX26Houston Eduardo Vilar #EndCancer